Beyond Biohacking Brothers

Beyond Biohacking Brothers
  • 5.0 (2)
  • MEDICINE
  • UPDATED WEEKLY

Where traditional biohacking intersects with precision medicine and genetic research in the pursuit of human excellence.

  1. 10H AGO

    Part 1 of 3: Roundtable with Dr. Drew Taylor | Secretome - The next-gen of stem cell regeneration

    WHO IS DR. DREW TAYLOR? Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics. Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach. Chapters 00:00 Why stem cells don’t heal 01:37 Meet Dr. Drew Taylor 03:30 What the Secretome is 05:23 FedEx analogy 07:10 Proof it works 09:22 Why stem cells fail 12:45 Safety of “from you” 16:47 Non-invasive capture

    23 min

  2. 10H AGO

    Part 2 of 3: Roundtable with Dr. Drew Taylor | Secretome - The next-gen of stem cell regeneration

    WHO IS DR. DREW TAYLOR? Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics. Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach. Chapters 00:00 Stem cell aging 01:37 Why “from you” works 03:30 Stem cells & decline 05:23 Aging is exponential 07:10 Skin, hair & inflammation 09:22 Aesthetics & recovery 12:45 Secretome vs PRP 16:47 FDA path & future use

    20 min

  3. 10H AGO

    Part 3 of 3: Roundtable with Dr. Drew Taylor | Secretome - The next-gen of stem cell regeneration

    WHO IS DR. DREW TAYLOR? Biotech scientist & founder of Acorn Biolabs, Dr. Drew Taylor leads personalized regenerative medicine by preserving your own cells and extracting the Secretome—healing signals for recovery, longevity & aesthetics. Stem cells aren’t the magic—their signals are. In Part 1, Dr. Drew breaks down the Secretome: growth factors & exosomes from your own cells, delivering stem-cell benefits with a safer, personalized approach. Chapters 00:00 Personalized regen vision 01:37 Why genetics matter 03:30 Donor stem risks 05:23 Third-gen regen 07:10 Cells as currency 09:22 Bank cells for life 12:45 Cost vs clinics 16:47 Why Acorn is unique

    25 min

  4. MAR 31

    Part 1 of 2: Roundtable with Shalin Shah | The 1st FDA approved oral Testosterone: Meet Kyzatrex

    WHO IS SHALIN SHAH? Founder, CEO, and visionary behind Marius Pharmaceuticals, the company that brought Kyzatrex to market—the first FDA-approved oral testosterone replacement therapy. With a background in private equity and investing, he moved into biotech to solve a long-standing problem in hormone health: making testosterone therapy more accessible, more practical, and aligned with modern lifestyles—while supporting education, stigma reduction, and better men’s health outcomes. In this two-part roundtable, the Biohacking Brothers sit down with Shalin Shah to break down why testosterone is a foundational longevity hormone, how Kyzatrex became the first FDA-approved oral testosterone, and what makes oral pulsatile dosing different from traditional injections. They cover cardiovascular and cognitive implications, stigma and access, fertility concerns, SHBG and free testosterone, estrogen myths, safety markers like hematocrit, and why patient education and proper lab interpretation matter—especially in a world where testosterone levels are declining across younger men.

    34 min

  5. MAR 31

    Part 2 of 2: Roundtable with Shalin Shah | The 1st FDA approved oral testosterone: Meet Kyzatrex

    WHO IS SHALIN SHAH? Founder, CEO, and visionary behind Marius Pharmaceuticals, the company that brought Kyzatrex to market—the first FDA-approved oral testosterone replacement therapy. With a background in private equity and investing, he moved into biotech to solve a long-standing problem in hormone health: making testosterone therapy more accessible, more practical, and aligned with modern lifestyles—while supporting education, stigma reduction, and better men’s health outcomes. In this two-part roundtable, the Biohacking Brothers sit down with Shalin Shah to break down why testosterone is a foundational longevity hormone, how Kyzatrex became the first FDA-approved oral testosterone, and what makes oral pulsatile dosing different from traditional injections. They cover cardiovascular and cognitive implications, stigma and access, fertility concerns, SHBG and free testosterone, estrogen myths, safety markers like hematocrit, and why patient education and proper lab interpretation matter—especially in a world where testosterone levels are declining across younger men.

    31 min

  6. FEB 24

    Part 1 of 3 - Sandra Kaufman: NAD explained by a world expert—facts vs fiction, and what works

    WHO IS SANDRA KAUFANN, MD? Dr. Sandra Kaufman is a physician and longevity scientist known for translating complex cellular aging science into practical, personalized health optimization strategies. Trained as an anesthesiologist with over two decades of clinical experience, she also has a background in cell biology—giving her a rare blend of real-world medicine and deep bench-science thinking. She’s the author of "The Kaufman Protocol: Why We Age and How to Stop It", where she introduces a structured longevity framework designed to move beyond generic “take these supplements” advice. Her work focuses on how and why cells decline over time, and how to intervene with evidence-based therapies—organized into what she calls the “Seven Tenets of Aging.” A key feature of her approach is a scoring/rating system that evaluates therapies by the strength of evidence (from theory and lab data to animal models and human outcomes), helping clinicians and patients build a longevity plan that’s more algorithmic and less guesswork.

    24 min

  7. FEB 24

    Part 2 of 3 - Sandra Kaufman: NAD explained by a world expert—facts vs fiction, and what works

    WHO IS SANDRA KAUFAN, MD? Dr. Sandra Kaufman is a physician and longevity scientist known for translating complex cellular aging science into practical, personalized health optimization strategies. Trained as an anesthesiologist with over two decades of clinical experience, she also has a background in cell biology—giving her a rare blend of real-world medicine and deep bench-science thinking. She’s the author of The Kaufman Protocol: Why We Age and How to Stop It, where she introduces a structured longevity framework designed to move beyond generic “take these supplements” advice. Her work focuses on how and why cells decline over time, and how to intervene with evidence-based therapies—organized into what she calls the “Seven Tenets of Aging.” A key feature of her approach is a scoring/rating system that evaluates therapies by the strength of evidence (from theory and lab data to animal models and human outcomes), helping clinicians and patients build a longevity plan that’s more algorithmic and less guesswork.

    24 min

  8. FEB 24

    Part 3 of 3 - Sandra Kaufman: NAD explained by a world expert—facts vs fiction, and what works

    WHO IS SANDRA KAUFAN, MD? Dr. Sandra Kaufman is a physician and longevity scientist known for translating complex cellular aging science into practical, personalized health optimization strategies. Trained as an anesthesiologist with over two decades of clinical experience, she also has a background in cell biology—giving her a rare blend of real-world medicine and deep bench-science thinking. She’s the author of The Kaufman Protocol: Why We Age and How to Stop It, where she introduces a structured longevity framework designed to move beyond generic “take these supplements” advice. Her work focuses on how and why cells decline over time, and how to intervene with evidence-based therapies—organized into what she calls the “Seven Tenets of Aging.” A key feature of her approach is a scoring/rating system that evaluates therapies by the strength of evidence (from theory and lab data to animal models and human outcomes), helping clinicians and patients build a longevity plan that’s more algorithmic and less guesswork.

    24 min
See All (58)

Ratings & Reviews

5
out of 5
2 Ratings

About

Where traditional biohacking intersects with precision medicine and genetic research in the pursuit of human excellence.

Information

  • Creator
    Beyond Biohacking Brothers
  • Years Active
    2024 - 2026
  • Episodes
    58
  • Rating
    Explicit
  • Copyright
    © All rights reserved.
  • Show Website
    Beyond Biohacking Brothers

You Might Also Like